Self-Testing Market Overveiw
The report is titled as ‘Self-Testing Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Self-Testing market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.
The self-testing market is estimated to reach at a value of US$ 20,465.0 Mn by the end of 2022 and expected to reach at a value of US$ 38,495.3 Mn by 2030 with a significant CAGR of 8.2%
Self-Testing Introduction
Over the past few years, the surge of consumer fascination towards self-testing technologies has raucously reclined on the increased repute of direct-to-home testing kits and strips. Self-testing is laying the ground for new methods to diagnose, monitor, and treat people and their conditions. It is significant to observe that following the late 2000, a wide range of self-testing kits have been employed for diagnosing various conditions, especially cancer-associated such as fecal occult blood and PSA, chronic ailments including diabetes and urinary tract infections. A self-testing basically means a test that can be carried out at home on one’s own in order to diagnose or determine various health issues. In addition, self-tests serve its utility as one of the several risk-downsizing measures that safeguards individuals by diminishing the odds of viral transmission. Owing to which, the self-testing kits are witnessing higher demand across the markets.
More importantly, self-test kits are extremely convenient and handy as well as comfortable for individuals as they can be used at any point of time and just require a small process. Some of the most convenient and handy self-test kits include HIV self-test kits, pregnancy self-test kits, STI self-test kits, infertility self-test kits, among others. Attributing to which, the global self-testing market is projected to rise significantly over the years.
Self-Testing Market Segmentation
The global self-testing market is segmented on the basis of product type, sample type, test type, distribution channel, application, and region.
By Product Type
Self-testing Kits
Self-collection Kits
Self-Testing Devices
Digital Monitoring Instruments
Self-testing Cassettes
Self-testing Midstreams
Self-testing Cups
Self-testing Dip Cards
Self-testing Panels
Others
By Application Type
Pregnancy Testing
Pulmonary Function Testing
Urinary Tract Infection Testing
Sexually Transmitted Infections (STIs) Testing
Genetic Testing
Vitamin Testing
Vitamin D
Vitamin B
Others
Mineral Deficiency Testing
Iron
Calcium
Others
COVID Testing
Allergy Testing
Pollen Allergy
Dust Mite Allergy
Others
Gastrointestinal Screening
Hormone Testing
TSH Testing
Menopause Testing
Others
Food Sensitivity Testing
Celiac Disease
Others
Infectious Diseases
By Sample Type
Saliva Sample
Nasal Sample
Stool Sample
Urine Sample
By Test Type
Point of Care Tests/Homecare Tests
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Supermarkets And Hypermarkets
Online
E-commerce
Online Pharmacies
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Self-Testing Market Key Players
Some of the key participating players in global Self-Testing market are:
Acon Laboratories Inc.
ARKRAY Inc.
Assure Tech (Hangzhou) Co. Ltd.
F. Hoffmann-La Roche AG
Siemens Healthineers
OraSure Technologies Inc.
Quest Diagnostics
Bionime Corporation
Becton, Dickinson and Company
Btnx Inc.
JR Biomedical Ltd.
Quidel Corporation
True Diagnostics Inc.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product developments and launches
Current product compliance
Reimbursement
Concerns for use of Self-Testing
Advantages of Self-Testing
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.
To learn more about this report, request a free sample copy
The self-testing market is estimated to reach at a value of US$ 20,465.0 Mn by the end of 2022 and expected to reach at a value of US$ 38,495.3 Mn by 2030 with a significant CAGR of 8.2%
The base year for the report is 2021 in self-testing market.
The global self-testing market is segmented on the basis of product type, sample type, test type, distribution channel, application, and region.
Abbott, Acon Laboratories Inc., ARKRAY Inc., Assure Tech (Hangzhou) Co. Ltd., F. Hoffmann-La Roche AG, Siemens Healthineers, OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation., Becton, Dickinson and Company, Btnx Inc., JR Biomedical Ltd., Quidel Corporation, and True Diagnostics Inc.,
The self-testing market is estimated to reach at a value of US$ 20,465.0 Mn by the end of 2022 and expected to reach at a value of US$ 38,495.3 Mn by 2030 with a significant CAGR of 8.2%.
The base year for the report is 2021 in self-testing market.
The global self-testing market is segmented on the basis of product type, sample type, test type, distribution channel, application, and region.
some of the key participating players in the self-testing market globally are Abbott, Acon Laboratories Inc., ARKRAY Inc., F. Hoffmann-La Roche AG, Siemens Healthineers, OraSure Technologies Inc., Quest Diagnostics, Bionime Corporation, Becton, Dickinson and Company, Btnx Inc., and JR Biomedical Ltd., among others.
